AQST News

AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026

Did You Lose Money Investing in Aquestive Therapeutics, Inc.? Robbins LLP Urges Investors With Significant Losses to Contact The Firm For Information About Their Rights Against AQST

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Aquestive Therapeutics, Inc. – AQST

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Aquestive Therapeutics, Inc. – AQST

Pomerantz LLP Alerts Shareholders to Investor Suit Against Aquestive Therapeutics, Inc. – AQST

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST

AQST SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 Ready to Announce with Confidence?

AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!